Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Chronic graft-versus-host disease: Where is promise for the future?
D. J. Weisdorf
Medicine - Hematology, Oncology, Transplant
Transplant and Cellular Therapy
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chronic graft-versus-host disease: Where is promise for the future?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Chronic Graft Versus Host Disease
100%
Graft Versus Host Reaction
100%
Diseases
22%
Oncology
11%
Clinical Study
11%
Chronic Disease
11%
Cyclosporine
11%
Supportive Care
11%
Infection Prevention
11%
Patient Referral
11%
Immune Deficiency
11%
Treatment Duration
11%
Hydroxychloroquine
11%
Prednisone
11%
Nutrition
11%
Proteans
11%
Nursing and Health Professions
Chronic Graft Versus Host Disease
100%
Graft Versus Host Reaction
100%
Diseases
22%
Pilot Study
11%
Disease Management
11%
Chronic Disease
11%
Syndrome
11%
Treatment Duration
11%
Ciclosporin
11%
Patient Referral
11%
Prednisone
11%
Immune Deficiency
11%
Infection Prevention
11%
Hydroxychloroquine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Graft Versus Host Reaction
100%
Chronic Graft Versus Host Disease
100%
Diseases
22%
Hydration
11%
Clinical Study
11%
Syndrome
11%
Chronic Disease
11%
Infection
11%
Ciclosporin
11%
Immune Deficiency
11%
Hydroxychloroquine
11%
Prednisone
11%
Keyphrases
Graft-versus-host Disease (GvHD)
100%
Prospective Randomized Trial
10%
Medical Management
10%
Cyclosporine
10%
Prednisone
10%
Children's Oncology Group
10%
Clinical High Risk
10%
Multicenter Trial
10%
Immune Deficiency
10%
Initial Treatment
10%
Supportive Care
10%
Support System
10%
Treating Physicians
10%
Standard Risk
10%
Chronic Illness
10%
Response Criteria
10%
Disease Manifestations
10%
Referral Center
10%
Infection Prophylaxis
10%
Hydroxychloroquine
10%
Length of Therapy
10%
Neuroscience
Ciclosporin
100%
Prednisone
100%
Hydroxychloroquine
100%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Chronic Graft Versus Host Disease
100%
Immunodeficiency
11%
Ciclosporin
11%
Prednisone
11%
Hydroxychloroquine
11%
Proteans
11%
Infection
11%